SHZ · 002653.SZ
Haisco Pharmaceutical Group Co., Ltd.
CN¥56.02-CN¥1.93 (-3.33%)
Haisco Pharmaceutical Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 30.69% below the high.
Loading market information…
SHH · 688578.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:58 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Shanghai Allist Pharmaceuticals Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 41.74% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Shanghai Allist Pharmaceuticals Co., Ltd.’s forward annual dividend is CN¥1.20 per share, paid semi-annual. The forward yield is 1.49% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Shanghai Allist Pharmaceuticals Co., Ltd.’s next earnings report is currently expected on Apr 28, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Shanghai Allist Pharmaceuticals Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in 2004, Shanghai Allist Pharmaceuticals Co., Ltd. is a Chinese enterprise dedicated to the innovation and development of medicinal products. Headquartered in Shanghai, the company focuses its efforts on creating therapeutic agents specifically for the treatment of various tumor and cancer-related conditions.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:13 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| CN¥0.82 |
| CN¥1.02B |
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥56.02-CN¥1.93 (-3.33%)
Haisco Pharmaceutical Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 30.69% below the high.
CN¥93.06-CN¥0.56 (-0.6%)
RemeGen Co. Ltd. Class A’s quoted price sits in the lower half of its reported 52-week range, 40.92% below the high.
CN¥4.75+CN¥0.05 (+1.06%)
Shanghai RAAS Blood Products Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 31.85% below the high.
CN¥32.08-CN¥0.03 (-0.09%)
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 51.85% below the high.
CN¥12.37-CN¥0.00 (0.0%)
Beijing Tiantan Biological Products Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.81% below the high.
CN¥82.36-CN¥1.84 (-2.19%)
Suzhou Zelgen Biopharmaceuticals Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 48.53% below the high.
CN¥40.63+CN¥0.59 (+1.47%)
Betta Pharmaceuticals Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 48.03% below the high.
CN¥27.08+CN¥0.06 (+0.22%)
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 34.22% below the high.
